Concord Drugs Ltd Share Price & Stock Analysis

Concord Drugs Ltd (BSE: 538965) is a Hyderabad, Telangana-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹96 Cr, it ranks #3,274 by market cap among the 6,197 Indian listed companies on FinBizNet, and #17 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹73.54 (as of 16 Nov 2026), the share price is 19.9% below its 52-week high of ₹91.79 and 22.6% above its 52-week low of ₹59.99. The share price is down 3.4% over one year and up 1.6% over three months.

Key Metrics

Current Price₹73.54
Market Cap₹96 Cr
BSE Code538965
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E Ratio77.7
Return on Equity2.55%
Return on Assets2.81%
52-Week Range₹59.99 – ₹91.79
1-Year Price Change-3.4%
3-Month Price Change+1.6%
Beta (1Y)0.48
HeadquartersHyderabad, Telangana
Websiteconcorddrugs.in

Shareholding and Delivery

Promoters held 51.43% of Concord Drugs Ltd's shares as of Mar 2026, against 51.39% in Mar 2025 (+0.04 percentage points). Delivery averaged 76.4% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Concord Drugs Ltd

Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products; ready-to-fill pellets and multiple unit pellets system; other drugs in the form of tablets, capsules, small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers. The company was incorporated in 1995 and is based in Hyderabad, India.

Products and Services

1. Manufacture of Pharmaceutical Formulations-This segment manufactures and sells finished pharmaceutical formulations. 2. Segment Adjustment-0 3. Trading-This segment engages in trading of packing material.

Business Segments

1. Pharmaceutical Products-100%

Concord Drugs Ltd vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Concord Drugs Ltd₹96 Cr77.72.55%—-3.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Concord Drugs Ltd?

Concord Drugs Ltd is trading at ₹73.54, with a market capitalisation of ₹96 Cr.

Which sector does Concord Drugs Ltd belong to?

Concord Drugs Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Concord Drugs Ltd?

Concord Drugs Ltd has a P/E of 77.7 and a return on equity of 2.55%.

What is the stock symbol of Concord Drugs Ltd?

Concord Drugs Ltd is listed on the BSE under the scrip code 538965.

How has Concord Drugs Ltd's share price moved over the past year?

Concord Drugs Ltd's share price is down 3.4% over one year and up 1.6% over three months. Its 52-week range is ₹59.99 to ₹91.79.

What is the promoter holding in Concord Drugs Ltd?

Promoters held 51.43% of Concord Drugs Ltd's shares as of Mar 2026, against 51.39% in Mar 2025 (+0.04 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.